跳至主要内容
临床试验/NCT06583122
NCT06583122招募中不适用

Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve

University of Kansas Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Reduction pain scores reported using an 11-point numeric rating scale (NRS)

研究概览

简要总结

Study an ultrasound guided approach to radiofrequency ablation of the occipital nerve that makes it possible to see the needle during treatment procedure. It is hoped this will reduce the amount of pain after the standard of care procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 18-80 with a diagnosis of occipital neuralgia or migraine overlying the occipital region.
  • A diagnosis of occipital neuralgia will be based on the International Classification of Headache Disorders (ICHD), whose criteria include: paroxysmal stabbing pain in the distribution of the GON, tenderness over the affected nerve, and relief of pain for at least 3 hours after bupivacaine local anesthetic block of the affected nerve.
  • Patients may also be included if they have a diagnosis of migraine based on the ICHD criteria with predominance of pain over the occipital region that responded to occipital nerve block.
  • Patients must have failed oral medications including NSAIDs, opioids, and anticonvulsants for the management of their pain.
  • Failed treatment will be <50% pain reduction with oral medication.
  • Patients must report headache frequency of at least 10 days per month.

排除标准

  • Patients will be excluded from the trial if they have an unstable medical or psychological condition,
  • are pregnant,
  • have an implanted cardiac pacemaker or defibrillator that could not be disabled,
  • have had a craniotomy or scar tissue overlying the site from a previous surgery,
  • have a history of cervical spine fusion,
  • have evidence of elevated ICP or intracranial tumor,
  • or have previous RFA treatment of the greater or lesser occipital nerve.

结局指标

主要结局

Reduction pain scores reported using an 11-point numeric rating scale (NRS)

时间窗: 18 Months

Pain scores will be assessed 0-10 at the beginning of the study and at the end. We will compare mean pain scores pre-intervention and post-intervention, and we expect mean pain scores will decrease by 4 points on the NRS

次要结局

  • Frequency of headache days(18 months)
  • Frequency of moderate-severe headaches(18 months)
  • Use of acute pain medications(18 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Timothy Sowder, MD

Principal Investigator

University of Kansas Medical Center

研究点 (2)

Loading locations...

相似试验